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Heterotopic cardiac transplantation 
with a xenograft1,2
In an active cardiac surgery unit many occasions arise where 
temporary assistance of the left ventricle in cardiogenic shock after 
cardiopulmonary bypass is needed. Although counter-pulsation with 
an intra-aortic balloon pumping apparatus will provide excellent 
assistance in the majority of cases, not all patients benefit from 
it. Partial assistance of the circulation with a pump oxygenator, 
although superior to balloon counter-pulsation, is not very practical 
for technical reasons. An artificial heart for routine use was not yet 
available at the time. This option became a possibility only during the 
past decade. The use of a heterotopic cardiac transplant is therefore 
ideal in this situation, i.e. to provide temporary support to the 
circulation until the recipient’s heart recovers.
Human donors, however, are not always available when required 
under these circumstances. High-risk procedures that may require 
such assistance can sometimes be postponed until a suitable donor 
is available. An alternative method is to use a xenograft heart 
temporarily for 3 - 4 days until the recipient’s heart has recovered. 
This was done on two occasions when a human donor was not 
available and other methods of assisting the circulation had failed.
The first patient to receive a heterotopic cardiac transplant using 
a xenograft was a 25-year-old woman who underwent repeat aortic 
valve replacement together with an aortoventriculoplasty procedure 
to enlarge a small aortic root. On completion of the operation the 
patient could not be weaned from the pump oxygenator despite 
institution of all conventional supportive measures, including the 
intra-aortic balloon pump. Heterotopic heart transplantation was 
performed using the heart of a 30 kg baboon. After this, all other 
mechanical support was able to be discontinued. The recipient 
heart, however, fibrillated repeatedly in the postoperative period and 
eventually would not respond to electrical defibrillation. The donor 
heart was not large enough to support the circulation adequately under 
these conditions, although it maintained a moderate circulation alone 
for about 30 minutes. This heart also eventually fibrillated, about 5 
hours postoperatively. At postmortem the recipient heart was found 
to have moderate but diffuse atherosclerosis of all major coronary 
arteries. The donor heart appeared to be normal macroscopically. 
On histological examination no signs of acute rejection were present, 
only a few contraction bands and mild interstitial oedema.
The second heterotopic xenograft heart transplant recipient was a 
60-year-old man who, after aortic valve replacement for severe calcific 
aortic stenosis, also could not be weaned from the pump oxygenator. 
This time the donor heart was obtained from a blood group A 
rhesus-positive male chimpanzee. The operation was uneventful 
and the patient was returned to the intensive care unit with good 
circulation and fully conscious. High doses of immunosuppressive 
drugs were administered. During the following few days a steady and 
gradual deterioration in the function of both hearts was observed. 
Once the recipient heart had fibrillated, the donor heart could not 
support the circulation owing to the severe acute rejection it had 
undergone in this 4-day postoperative period. This rejection process 
was histologically documented at postmortem.
With the current development of mechanical circulatory support 
systems, this type of surgery is probably no longer necessary.
Orthotopic transplantation of a 
baboon heart after 20 - 24 hours’ 
preservation3,4
Of patients accepted for cardiac transplantation, up to 50% die from 
progression of their cardiac disease while awaiting transplantation. In 
order to increase the availability of donor hearts, organs have to be 
procured from other centres in the country.
Short-term preservation of the donor heart, for up to 5 hours, 
has been successfully accomplished for many years, both locally 
and abroad. The method used for short-term preservation 
consists of initial cardioplegic arrest of the donor heart with a 
hyperkalaemic and hypertonic solution, together with topical cooling 
of the myocardium. After this the heart is harvested, placed in a 
sterile container containing cold saline, and then packed in ice for 
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transportation. The clinical results following this procedure have 
been excellent. However, the cost is prohibitive as hire of a private 
aircraft is required. Also the time is too short for very long distances 
to be covered. A method of safe prolonged myocardial preservation 
would overcome these drawbacks, as there would be sufficient time 
to make use of commercial flights for transportation. The cost of 
obtaining donor hearts from distant centres would then be minimal. 
Our experimental efforts in this direction have proved that donor 
hearts can be successfully preserved for up to 24 hours.
Baboon hearts were rapidly excised after being flushed with 500 ml 
of cardioplegic solution at 4oC and then immersed in cold -4oC saline 
or cardioplegic solution for 2 minutes. The hearts were then perfused 
at a pressure of 8 - 10 cmH2O for 20 - 24 hours under refrigeration 
with a hyperosmolar clear fluid perfusate at 6 - 8oC through which 
95% oxygen and 5% carbon dioxide were continually bubbled 
to maintain the perfusate pH between 7.2 and 7.4. Myocardial 
temperature remained at approximately 6 - 8oC. The hearts were 
then orthotopically transplanted into recipient baboons matched for 
size and AB blood group the next day. Two groups (A and B) were 
studied, differing significantly only in respect of the constitution of 
the cardioplegic solution and perfusate used. The cardioplegic agent 
used in group B contained a higher concentration of magnesium than 
that used in group A, and included the calcium antagonist verapamil. 
Perfusate B had higher osmolality than perfusate A, largely owing 
to the inclusion of sucrose. A preliminary group of 10 baboons in 
group A received no immunosuppression. Five of the remaining 
6 immunosuppressed baboons in this group survived more than 
48 hours to rejection or until sacrificed at 2 - 29 days. Cardiac 
catheterisation was performed in 6 surviving baboons (4 in group A, 
2 in group B) between postoperative days 6 and 10 and showed good 
haemodynamic function. Histological examination of the hearts after 
death has shown only minor ischaemic changes in the hearts that 
functioned well.
Haemodynamic and metabolic effects 
of brain death on the donor heart
This subject was the topic of investigation in the research laboratory 
by a research team and was undertaken once the programme 
investigating prolonged preservation of the heart had been completed. 
Major haemodynamic changes definitely do occur after donor brain 
death, mainly owing to the diabetes insipidus caused by the brain 
oedema and elevated intracranial pressure. A consequence is loss 
of excessive amounts of fluids that in turn results in haemodynamic 
instability. To counteract this, large amounts of fluids are transfused 
to the donor together with inotropic agents and vasopressin. It follows 
that with these fluid changes, metabolic effects may occur as well.
Endocrine changes found to occur included catecholamine 
secretion and thyroid hormone depletion.5 In a further study,6 
beneficial effects of hormonal therapy in donor management were 
shown. However, other studies in the literature, although they do 
document hormonal changes in the brain-dead animals or the 
donors, could not find any benefit in hormonal therapy.7,8 This topic 
remains very controversial.
Experimental heterotopic heart and 
single right lung transplantation 
(unpublished) 
The transplantation of heart and lungs en bloc has the advantage of 
replacing these diseased organs in the recipient with healthy ones, 
thus deriving maximal physiological benefit from this procedure. 
Furthermore, all diseased recipient lung tissue, which could be a 
source of infection during the period of heavy immunosuppression, 
is removed. In certain conditions that would benefit from heart 
and lung transplantation however, such as Eisenmenger syndrome, 
idiopathic pulmonary hypertension and extreme pulmonary atresia, 
the retention of one relatively ‘healthy’ lung may be beneficial. 
Complete denervation of the whole respiratory tract is avoided, 
which may retain a more physiological respiratory pattern in the 
postoperative period. Consequently, this normal respiratory function 
will help prevent or diminish the magnitude of postoperative 
complications, including the lung ‘reimplantation’ response. With 
these considerations in mind we developed a method for the 
heterotopic transplantation of the heart together with the right lung 
en bloc after right pneumonectomy of the recipient.
Experimentation to prove the technical feasibility of this procedure 
was carried out in the animal laboratory. Briefly, the technique is 
as follows. Baboons weighing between 15 and 25 kg, matched for 
size and AB blood groups, were used. Two of the operations were 
performed through a right lateral thoracotomy through the 4th 
intercostal space, one with the aid of cardiopulmonary bypass and one 
without. A further 2 operations were performed through a median 
sternotomy; again, one was performed utilising cardiopulmonary 
bypass and one without.
Pneumonectomy of the recipient right lung was performed using 
standard techniques. The pericardial sac was opened above the right 
phrenic nerve and a piece of pericardium removed in the same 
fashion as for heterotopic heart transplantation. The donor heart 
and right lung were removed en bloc. After cardioplegic arrest of the 
heart and topical cooling of both donor organs, the pulmonary artery 
and veins were ligated and divided. The inferior vena cava was then 
ligated and divided. Next, the superior vena cava and ascending aorta 
were divided. The right bronchus was divided nearer the hilum than 
the carina to avoid possible ischaemia at the bronchial anastomosis 
site later on (Fig. 1). Further pericardial and hilar attachments of 
these organs were freed, taking control of possible bleeding sites that 
could occur after transplantation.
In this series of experiments great care was taken in the construction 
of the bronchial anastomosis. This contributed to the successful 
outcome in all 4 cases. The donor bronchus was telescoped into the 
recipient bronchus and the tissue of the suture line bolstered with 
vascularised tissue where possible.
For completion of the operation (Fig. 2), the donor superior vena 
cava was anastomosed end-to-side to the recipient superior vena 
cava-right atrium junction, this anastomosis being made as wide as 
possible, and similarly the donor ascending aorta was anastomosed 
to the recipient ascending aorta in an end-to-side manner as well 
(Fig. 3). On releasing the superior vena cava and aortic side-clamps 
on completion of the anastomoses, a severe drop in blood pressure 
was experienced if the animal was not on cardiopulmonary bypass. 
In order to overcome this, prompt blood transfusion was necessary. 
Great care had to be taken to remove air from the donor left ventricle.
All animals lived for an average of 5 days postoperatively, and all 
died as a result of pulmonary oedema in the transplanted lung. At 
autopsy the bronchial anastomosis was found to be intact and open 
widely in all animals. No necrosis or tissue ulceration was observed. 
The cause of the pulmonary oedema in these experiments was 
thought to be a combination of ‘reimplantation’ response and early 
acute rejection. Although ‘conventional’ immunosuppression was 
given to these animals, no other efforts were made to distinguish 
between the two possible causes of this phenomenon and no 
added therapy was attempted. Our main concern was the technical 
feasibility of the operation.
Our conclusions were that the operation can be performed 
just as easily through a right lateral thoracotomy as through a 
FORUM
352  June 2012, Vol. 102, No. 6  SAMJ
median sternotomy, and that cardiopulmonary bypass can be 
instituted as easily from either approach. Cardiopulmonary bypass 
is not essential in the experimental situation, but may be necessary 
clinically when the recipient’s left lung is diseased. To ascertain 
this, temporary clamping of the right lung before institution of 
cardiopulmonary bypass is necessary. The bronchial anastomosis 
should not be a cause for concern when performed in the manner 
described. Better immunosuppression for lung transplantation, as 
afforded by cyclosporin A alone or in combination with other more 
recent drugs, will be necessary in the clinical situation. Although 
unilateral lung transplants have been shown to afford only a modest 
improvement in the recipient’s condition in the past, unilateral lung 
and heart transplantation does have a definite theoretical advantage 
in a select group of recipients.
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Fig. 1. The donor heart and right lung harvested en bloc and prepared for 
transplantation.
Fig. 2. The donor superior vena cava anastomosis, end-to-side, to the 
recipient superior vena cava–right atrium junction.
Fig. 3. The end-to-side anastomosis of the donor ascending aorta to the 
recipient ascending aorta.
